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Abstract
Background: Recently, robot-assisted neck dissection (ND) using a transaxillary approach in thyroid cancer
patients with lateral neck metastases (LNM) was demonstrated to be feasible. The aim of this study was to
compare the surgical outcomes of a modified transaxillary and retroauricular (TARA) versus a conventional
transcervical approach in papillary thyroid carcinoma (PTC) patients with LNM.
Patients and Methods: In total, 47 patients with PTC underwent total thyroidectomy with central compartment
ND and modified radical ND except Level I. Twenty-two NDs were performed via the TARA approach, and 25
unilateral NDs were performed via the conventional transcervical approach.
Results: The TARA and the open ND groups consisted of 22 and 25 patients, respectively. The operation time for
ND in the TARA group was longer than that in the open ND group (209.4– 38.2 minutes versus 143.1– 30.5
minutes; P= .000). The mean scar satisfaction score in the TARA group was higher than in the conventional ND
group (3.9– 1.0 versus 2.8– 1.0;P= .000). There were no differences in the mean number of retrieved lymph nodes.
Conclusions: The robot-assisted ND via the TARA approach can be an alternative option that produces
excellent esthetic results for the management of LNM in PTC patients.
Introduction
Cervical lymph node metastases are frequently en-countered in the management of papillary thyroid carci-
noma (PTC).1 Since the introduction of robotic thyroidectomy,
robot-assisted neck dissection (RAND) using a transaxillary
approach in thyroid cancer patients with lateral neck meta-
stases (LNM) has been studied and demonstrated to be feasi-
ble.2 However, access to the upper neck levels (e.g., Levels II
and VA) is restricted with this approach, and clearance of
lymphofatty tissues in those areas may be questionable. We
previously assessed the difficulty of dissecting Level II via the
transaxillary approach in a cadaveric study.3
According to studies examining the pattern of nodal me-
tastasis in PTC, although the incidences of lymph node me-
tastasis in Level IIB were 21%4 and 22%,5 the incidence of
metastatic disease in Level II ranges from 52% to 72.2%.6,7
These sizeable figures prompted us to devise a modified ap-
proach, called the transaxillary and retroauricular (TARA)
approach, which was shown to be feasible for the manage-
ment of nodal metastasis in head and neck cancer.8
The aim of this study was to compare the surgical out-
comes of the TARA approach with those of a conventional
transcervical approach for the management of LNM in PTC.
We describe the application of the TARA approach to the
management of LNM in PTC with the expectation that it
would lead to superior clearance of Level II nodes.
Patients and Methods
Patients
After approval was obtained from the Institutional Review
Board of Severance Hospital, Yonsei University College of
Medicine, Seoul, Korea, patients with PTC and LNM were
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enrolled in this study. From June 2010 to April 2012, in total,
47 patients with PTC underwent total thyroidectomy with
central compartment neck dissection (CCND) or total thy-
roidectomy with modified radical neck dissection (MRND)
except Level I at our institution.
The inclusion criteria were as follows: (1) biopsy-proven
PTC in LNM, (2) no previous treatment for PTC, and (3)
nodal metastases without extracapsular spread on preopera-
tive imaging studies. Patients with the following criteria were
excluded: (1) recurrent tumor, (2) distant metastasis at the
initial presentation, or (3) suspected extracapsular spread of
LNM.
The selection of the approach method for neck dissection
(ND) was based on the patient’s preference after the patient
was fully informed about the advantages and disadvantages
of each approach. Informed consent was obtained from every
patient.
The following variables were assessed: age, gender, op-
eration time for ND, total amount of postoperative drainage,
duration of drainage, duration of hospital stay, perioperative
complications, primary tumor size, and mean numbers of
retrieved and metastatic lymph nodes by neck level. Post-
operative thyrotropin (thyroid-stimulating hormone [TSH])-
suppressed serum thyroglobulin (TG) levels were checked at
1 month after surgery and before radioactive iodine remnant
ablation (RRA) was performed. All patients underwent
high-dose (150mCi) RRA postoperatively. TSH-stimulated
serum TG levels after RRA were also checked. Scar satis-
faction scores were measured at 3 months postoperatively
using a 5-point scale (1= extremely dissatisfied, 2 = dissat-
isfied, 3 = average, 4 = satisfied, and 5= extremely satisfied).
The mean follow-up period was 16.8– 11.7 months. A single
surgeon (Y.W.K.) performed all operations in this study.
Operative techniques
Robot-assisted total thyroidectomy, CCND, and MRND via
the TARA approach. The detailed procedures for the TARA
approach were described previously,6 and the overall concept
is depicted in Figure 1. In brief, a retroauricular (RA) incision
was made around the RA sulcus and the hairline. After flap
elevation (Fig. 2A), the posterior belly of the digastric muscle
was sought by dissecting the lower border of the subman-
dibular gland. The spinal accessory nerve (SAN) was iden-
tified at the posterior border of the sternocleidomastoid
muscle (Fig. 2B). The entire course of the SANwas identified
and skeletonized (Fig. 2C). While the sternocleidomastoid
muscle was retracted laterally, Levels IIB, VA, and IIA, as
well as the upper Level III, were dissected consecutively
(Fig. 2D). A 7-cm incision was made at the anterior border of
the axillary fossa, and the skin flap was elevated above the
pectoralis major. The flap elevation was continued superiorly
up to the previously dissected upper neck levels and medially
to the contralateral thyroid gland. After a working space was
created, a self-retaining retractor (Chung’s retractor) was
placed. A 30 endoscope was placed in the central arm of the
da Vinci surgical robot (Intuitive Surgical, Sunnyvale, CA)
and inserted in the midline skin incision. Harmonic (Ethicon,
a Johnson & Johnson Company, New Brunswick, NJ) curved
shears and Maryland forceps were placed on either side of the
endoscope. The robot-assisted dissection of Levels III, IV, and
VB via the transaxillary incision then proceeded (Fig. 3).
Total thyroidectomy and CCND procedures were per-
formed via the transaxillary incision. A 1-cm skin incision was
made in the areolar area, and ProGrasp (Intuitive Surgical)
forceps were placed through the trocar. After exposure of its
upper pole, the thyroid gland was drawn downward using the
forceps. The superior thyroid vessels were ligated with Har-
monic curved shears. The tracheal wall was identified as a
midline reference point. The inferior thyroid artery was then
ligated close to the thyroid gland. The thyroid gland was dis-
sected from the trachea in Berry’s ligament area, taking care
not to injure the recurrent laryngeal nerve (RLN). The isthmus
was resected, and the lobectomy specimen was extracted. A
contralateral lobectomy was performed through the same in-
cision by subcapsular dissection, preserving the parathyroid
glands and the RLN. CCND was performed with preserva-
tion of the preidentified RLN. After removal of the specimen,
the operative field was irrigated with sterile saline. A closed
suction drain was placed through the transaxillary incision.
After the subcutaneous layer was closed, the transaxillary in-
cision was closed with a vertical mattress stitch, and the RA
incision was closed with a simple suture technique.
Total thyroidectomy, CCND, and MRND via the conven-
tional transcervical approach. Acurvilinear single transverse
incision about 10 cm in length was made two fingerbreadths
above the sternal notch on the anterior neck. A skin flap was
elevated superiorly to the lower border of submandibular
gland, inferiorly to the clavicle, and laterally to the medial
border of the trapezius muscle on the side of the ND. MRND
was done first, and a total thyroidectomy with CCND was then
performed using a Harmonic scalpel. The surgical field was
then irrigated with sterile saline, and a closed suction drain was
placed next to the skin incision. The subcutaneous layer
was closed, and the skin was approximated with Steri-strips
(3M, St. Paul, MN).
FIG. 1. Schematic drawing of the transaxillary and ret-
roauricular approaches. Upper neck dissection (Levels IIA,
IIB, and VA, as well as the upper III level) can be performed
under direct visualization through the retroauricular incision
(upper outline). The medial aspect of the carotid space in
Level IIA can be accessed via both the retroauricular and
transaxillary approaches for the competent clearance of
lymphofatty tissues. Robot-assisted lower neck dissection
(Levels IV and VB) and thyroidectomy can be performed
through the transaxillary incision (lower outline).
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FIG. 2. Upper neck dissection via a retroauricular approach under direct visualization. (A) Creation of a working space
on the right side. The external jugular vein (EJV), greater auricular nerve (GAN), and spinal accessory nerve (SAN) near
Erb’s point were identified. SCM, sternocleidomastoid muscle. (B) SAN identification near Erb’s point on the left side.
(C) Level IIA, IIB, and upper III lymph node dissection on the left side. The SAN to SCM (SANs) and SAN to the
trapezius muscle (SANt) were identified and followed to the level of the trapezius. There were no injuries to the vascular
structures, including the carotid artery (CA) and internal jugular vein (IJV). (D) Level IIA, IIB, and upper III lymph
node dissection on the left side. The SAN, hypoglossal nerve (HN), ansa hypoglossi (AH), IJV, and CA were identified
and preserved.
FIG. 3. Robot-assisted neck dissection via a transaxillary port in the left side. (A) Omohyoid muscle resection at Level
V. (B) Level IV dissection. (C) Cervical plexus dissection. (D) Carotid sheath dissection. (E) Surgical field. The phrenic
nerve and brachial plexus are seen beneath the fascial carpet. (F) Surgical field. The digastric muscle (DG), hypoglossal
nerve (HN), spinal accessory nerve (SAN), carotid artery (CA), internal jugular vein (IJV), and submandibular gland
(SMG) were noted.
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Statistical analysis
Statistical analyses were performed using Student’s t test,
the chi-squared test, Fisher’s exact test, or the Mann–Whitney
U test. Two-sided P values < .05 were deemed statistically
significant.
Results
Patients, operative parameters, postoperative outcomes,
and complications
Patient information, operative parameters, postoperative
outcomes, and complications are shown in Table 1. The
TARA group consisted of 17 females and 5 males with a
mean age of 40.1 years. The open ND group consisted of 12
females and 13 males with a mean age of 45.3 years.
The operation time for ND in the TARA group was sig-
nificantly longer than in the open ND group (209.4– 38.2
minutes versus 143.1– 30.5 minutes; P= .000). The identifi-
cation of the SAN, hypoglossal nerve, and RLNwas successful
in all cases. The mean postoperative serum TG levels (TSH-
suppressed before RRA) in the TARA group and the open ND
group were 0.31– 0.58 ng/mL and 0.67– 0.97 ng/mL, respec-
tively (P= .119). The mean postoperative serum TG level
(TSH stimulated) in the TARA group was 2.51– 3.97 ng/mL
and in the open ND group was 1.27– 2.32 ng/mL (P= .207).
The mean amounts of drainage from the surgical site in the
TARA group and the open ND group were 622.6– 263.5mL
and 658.8– 204.7mL, respectively (P= .599). Themean drain-
age duration was 6.7– 1.4 days in the TARA group and
7.4– 1.9 days in the open ND group (P= .180). The dura-
tions of hospital stay in the TARA group and the open ND
group were 9.2 – 1.8 days and 8.5 – 1.8 days, respectively
(P = .192). In the TARA group, postoperative complications
included 2 cases of postoperative seroma, 1 case of hema-
toma, 6 cases of transient hypoparathyroidism, and 1 case of
chyle leakage. In the open ND group, there were 4 cases of
seroma, 1 case of hematoma, 7 cases of transient hypopara-
thyroidism, and t2 cases of chyle leakage. All seroma cases
resolved after needle aspiration. Each case of postoperative
hematoma, regardless of procedure approach, was the result
of minor bleeding from the skin flap and was successfully
managed with a compressive dressing. All cases of transient
hypocalcemia resolved within 2 months. Chyle leakages
were managed with a fat-free diet and by placing a com-
pressive dressing over the supraclavicular fossa; all resolved
within 1 week. Six patients in the TARA group and 4 patients
in the open ND group experienced postoperative numbness of
the earlobe. Two patients in the TARA group and 2 patients
in the open ND group experienced transient hoarseness, but
none of these cases persisted for longer than a month. In all
cases, the SAN, RLN, and hypoglossal nerve were success-
fully identified and preserved. There were no cases of tem-
porary mouth corner deviation in either group. There were no
cases of transaxillary or periareolar approach-specific com-
plications (i.e., brachial plexus injury or skin flap injury)
except chest wall seroma in 1 case in the TARA group.
Overall, there were no significant differences in the devel-
opment of postoperative complications between both groups.
The mean scar satisfaction score in the TARA group was
higher than that in the conventional ND group (3.9 – 1.0
versus 2.8 – 1.0; P = .000) (Fig. 4). The mean follow-up was
15.9 – 5.2 months in the TARA group, compared with
17.6 – 15.3 months in the conventional group (P= .607).
Pathologic characteristics
The pathologic characteristics are summarized in Table 2.
The mean primary tumor size was 11.68– 6.80mm in the
TARA group and 12.20 – 7.48mm in the open ND group
Table 1. Clinical Information, Operative Parameters, Postoperative Outcomes, and Complications
RAND (n = 22) Open ND (n = 25) P value
Mean age (years) 40.1 (23–55) 45.3 (14–74) .191
Sex ratio (male:female) 5:17 13:12 .070
Operation time for ND (minutes) 209.4 – 38.2 143.1 – 30.5 .000
Flap elevation 81.6 – 10.5 — —
Docking 9.8 – 4.5 — —
Console 118.0 – 32.7 — —
Serum TG levels (ng/mL)
TSH-suppressed before RRA 0.31 – 0.58 0.67 – 0.97 .119
TSH-stimulated after RRA 2.51 – 3.97 1.27 – 2.32 .207
Conversion to open surgery None None —
Amount of drainage (mL) 622.6 – 263.5 658.8 – 204.7 .599
Duration of drainage (days) 6.7 – 1.4 7.4 – 1.9 .180
Duration of hospital stay (days) 9.2 – 1.8 8.5 – 1.8 .192
Seroma 2 (9.1%) 4 (16%) .670
Hematoma 1 (4.5%) 1 (4%) 1.000
Transient hypoparathyroidism 6 (27.3%) 7 (28%) 1.000
Chyle leakage 1 (4.5%) 2 (8%) 1.000
Earlobe numbness 6 (27.3%) 4 (16%) .480
Transient hoarseness 2 (9.1%) 2 (8%) 1.000
Scar satisfaction score 3.9 – 1.0 2.8 – 1.0 .000
Mean follow-up (months) 15.9 – 5.2 17.6 – 15.3 .607
ND, neck dissection; RAND, robot-assisted neck dissection; RRA, radioactive iodine remnant ablation; RLN, recurrent laryngeal nerve;
TG, thyroglobulin; TSH, thyroid-stimulating hormone.
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(P = .806). Eleven cases in the TARA group and 7 cases in the
open ND group had multiple thyroid gland lesions (P = .144).
Six cases in the TARA group and 9 cases in the open ND
group had evidence of thyroid capsular invasion (P = .550).
Three cases in the TARA group and 2 cases in the open ND
group had expanding margin (P = .654). There were no sig-
nificant differences in the mean number of retrieved lymph
nodes by neck level or in the absolute total number of lymph
nodes retrieved except in the mean number of retrieved
lymph nodes of Level IIB. The mean number of retrieved
lymph nodes of Level IIB was 4.09 – 2.43 in the TARA group
and 2.36 – 1.85 in the open ND group (P= .008). Incidences
of lymph node metastasis in (1) Level IIB, (2) Level VA, and
(3) the sum of Level IIB or VA were (1) 19.1% (9/47) (22.7%
[5/22] in the TARA group, 16.0% [4/25] in the open ND
group), (2) 4.3% (2/47) (0% [0/22] in the TARA group, 8.0%
[2/25] in the open ND group), and (3) 21.3% (10/47) [22.7%
(5/22) in TARA group, 20.0% (5/25) in the open ND group],
respectively. The differences in the number of pathologic
lymph nodes by neck level and in the mean number of total
pathologic lymph nodes were not statistically significant.
Discussion
Recent progress in endoscopic and robotic technologies has
enabled substantial advances in surgical techniques. With the
introduction of endoscopic thyroidectomy,9 minimally inva-
sive surgeries aiming to minimize scar visibility have been
extensively studied and widely applied in the field of thyroid
surgery.10–12 In particular, Kang et al.13 reported 338 cases of
robotic thyroid surgery using a gasless transaxillary approach.
They were the first to extend the indications for robot-assisted
endoscopic surgery to include ND.2 Adopting their method,
we identified limitations to complete extirpation of upper-
neck-level nodes by a cadaveric study and accumulation of our
own experience.3 According to studies documenting nodal
metastasis patterns in PTC, the incidence of Level II including
IIB lymph nodes cannot be disregarded, suggesting a need for
a modified approach to completely remove upper-neck-level
nodes.6–9 Following our report on the feasibility of the TARA
approach in head and neck cancer,8 we applied the TARA
approach in the management of PTC with LNM, expecting
competent extirpation of Level II lymph nodes.
There were no significant differences between the TARA
group and the conventional ND group regarding the number
of retrieved lymph nodes by neck level. Studies by Kang
et al.2 reported an average of 7.3 lymph nodes retrieved from
Level IIA, and they did not routinely dissect Level IIB. In-
clusion of Level IIB in our study may be one of the factors
leading to a higher retrieval of Level II lymph nodes, al-
though we cannot compare our results statistically with these
earlier studies. However, we speculate that good accessibility
under direct vision for Level II dissection and less concern
regarding injury to the SAN and the hypoglossal nerve in the
TARA approach may have helped with competent clearance
of lymph nodes in that area.
FIG. 4. Postoperative photographs of patients who un-
derwent total thyroidectomy with modified radical neck
dissection. (A and B) The anterior transverse cervical inci-
sion sometimes resulted in a disfiguring hypertrophic scar.
(C and D) Both the retroauricular and transaxillary incisions
could be hidden.
Table 2. Pathologic Characteristics
in the Robot-Assisted Neck Dissection Group
and the Open Neck Dissection Group
RAND
(n= 22)
Open ND
(n = 25)
P
value
Primary tumor size (mm) 11.68 – 6.80 12.20– 7.48 .806
Multiplicity 11 (50%) 7 (28%) .144
Extrathyroidal extension 6 (27%) 9 (36%) .550
Thyroidectomy margin
(expanding:infiltrative)
3:19 2:23 .654
Retrieved LN per CCND 7.1 – 4.7 7.2– 3.9 .934
Retrieved LN per MRND
II 10.36 – 5.47 8.32 – 3.93 .145
IIA 6.27 – 3.98 5.96 – 3.42 .773
IIB 4.09 – 2.43 2.36 – 1.85 .008
III 8.18 – 4.56 7.44 – 2.40 .499
IV 7.91 – 4.84 8.84 – 3.14 .433
V 6.68 – 2.46 6.64 – 2.55 .955
VA 1.95 – 1.53 2.40 – 1.85 .376
VB 4.73 – 1.80 4.24 – 2.42 .443
Total 33.14 – 10.72 31.24– 5.29 .457
Pathologic LN per CCND 2.0 – 2.0 2.3– 2.2 .654
Pathologic LN per MRND
II 1.59 – 1.76 1.20 – 1.44 .408
IIA 1.27 – 1.20 1.04 – 1.27 .525
IIB 0.32 – 0.72 0.16 – 0.37 .339
III 2.14 – 1.96 1.68 – 1.07 .338
IV 1.45 – 1.53 1.48 – 1.96 .961
V 0.36 – 0.79 0.28 – 0.61 .685
VA 0.00 – 0.00 0.08 – 0.28 .161
VB 0.36 – 0.79 0.20 – 0.50 .395
Total 5.55 – 3.54 4.64 – 3.45 .380
CCND, central compartment neck dissection; LN, lymph node;
MRND, modified radical neck dissection except Level I; ND, neck
dissection; RAND, robot-assisted neck dissection.
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Except for the operation time for ND, the operative par-
ameters were comparable between the groups. The mean time
required for ND in the TARA group was significantly longer
than in the conventional ND group, mainly because of the flap
elevation and docking time. Unlike open ND, the TARA ap-
proaches requires space for the robotic instrumentation.
However, the time for flap elevation aswell as the console time
is decreasingwith the accumulation of clinical experience, and
we are currently planning amore in-depth study of the learning
curve of RAND procedures via the TARA approach.
RAND via the TARA approach is not without weaknesses,
particularly with regard to invasiveness. As we commented in
our previous study,12 the terms ‘‘endoscopic’’ and ‘‘robotic’’
do not necessarily imply ‘‘minimally invasive.’’ Although we
can expect superior oncologic outcomes (i.e., competent re-
trieval of lymph nodes) with the TARA approach, it does tend
to be more invasive than the more limited TA approach, which
is already considered an aggressive approach compared with
the conventional external approach. The TARA approach also
faces criticism due to its excessive level of tissue dissection.
However, the competent clearance of lymph nodes in which
occult metastasis may exist cannot be overemphasized, even at
the expense of procedural invasiveness. Although a prospec-
tive study regarding oncologic outcomes of open, transax-
illary, and TARA approaches should be elucidated, we still
speculate that the complete removal of lymph nodes in Level
IIB and VA can be done via the TARA approach in cases of
multiple LNM. However, we also advocate that the TA ap-
proach may be an option in cases in which there is no evidence
of Level IIb or Va metastasis from preoperative imagings.
There are some limitations to this study. This was a ret-
rospective review of two groups that were not randomized or
matched. The decision as to surgical approach was made
mainly by informed patient preference, which may have led
to selection bias. In particular, in Korea, the procedural cost
for RAND is about seven times that of conventional ND. In
addition, unlike open ND, in which a landmark stitch within
the specimen can be made to indicate the boundary of each
neck level, the sorting of neck levels in robot-assisted ND is
somewhat arbitrary. However, at our center, after the speci-
men is extracted, the surgeon divides each neck compartment
very carefully in order to achieve accuracy. Finally, in this
preliminary report, we were able to compare only the im-
mediate surgical outcomes between the TARA group and the
conventional ND group. We compared the postoperative
serum TG levels of both groups before and after RRA and
found no significant differences. Therefore, the reliability of
the TARA approach as a method of surgical extirpation for
PTC with LNM can be substantiated.
In conclusion, we successfully performed RAND via a
novel TARA approach in PTC patients with LNM. The sur-
gical outcomes of this approach were comparable with those
of conventional ND. This approach is an alternative option
with an excellent esthetic result for the management of LNM
in PTC patients. The long-term outcomes of RAND via the
TARA approach should be further assessed to determine its
oncologic safety.
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